Annual FEV1 Loss in Patients with Noncystic Fibrosis Bronchiectasis and Affecting Factors

被引:2
作者
Borekci, Sermin [1 ]
Gundogdu, Sule [1 ]
Harbiyeli, Deniz Ongel [1 ]
Musellim, Benan [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Pulm Dis, Istanbul, Turkey
关键词
bronchiectasis; FEV1; lung function; Pseudomonas colonization; PULMONARY-FUNCTION; LUNG-FUNCTION;
D O I
10.14423/SMJ.0000000000001394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Bronchiectasis is a chronic respiratory disease characterized by sputum production, cough, and several bronchial infections. Lung function is an important parameter to evaluate and study in patients with bronchiectasis. This study aimed to evaluate the annual changes in forced expiratory volume in one second (FEV1) and related factors in patients with with noncystic fibrosis bronchiectasis. Methods A total of 529 patients who were diagnosed as having bronchiectasis using computed tomography and followed at the bronchiectasis unit of the Cerrahpasa Medical Faculty at Istanbul University between 1996 and 2018 were included in this retrospective study. A total of 153 patients were included in the study. Results The mean age of the patients was 58.6 +/- 16.8 years and 61% (n = 93) were female. The annual change of FEV1 and forced vital capacity was -39 +/- 82 (minimum: -585, maximum: 355, median: -26) mL and - 44 +/- 91 (minimum: -517, maximum: 303, median: -31) mL, respectively. There was no correlation in FEV1 decline between those with and without Pseudomonas colonization (P = 0.65). No correlation was found between the etiologic factors and the decline of FEV1. A correlation existed only between the first FEV1 and the decline of FEV1 (for the first FEV1%, P = 0.038 [R = -0.17]; for the first FEV1 [mL] P = 0.026 [R = -0.18]). Conclusions An annual mean FEV1 loss of 39 mL was found in adult patients with noncystic fibrosis bronchiectasis. The annual mean FEV1 decline was found to be associated with the baseline FEV1 value. Physicians should exercise caution in this regard in patients with bronchiectasis with low FEV1 values.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 50 条
  • [21] Volumetric Capnography for the Evaluation of Pulmonary Disease in Adult Patients with Cystic Fibrosis and Noncystic Fibrosis Bronchiectasis
    L. Veronez
    M. M. Moreira
    S. T. P. Soares
    M. C. Pereira
    M. A. G. O. Ribeiro
    J. D. Ribeiro
    R. G. G. Terzi
    L. C. Martins
    I. A. Paschoal
    Lung, 2010, 188 : 263 - 268
  • [22] Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States
    Ramos, Kathleen J.
    Quon, Bradley S.
    Heltshe, Sonya L.
    Mayer-Hamblett, Nicole
    Lease, Erika D.
    Aitken, Moira L.
    Weiss, Noel S.
    Goss, Christopher H.
    CHEST, 2017, 151 (06) : 1320 - 1328
  • [23] Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial
    Kriemler, Susi
    Kieser, Stephanie
    Junge, Sibylle
    Ballmann, Manfred
    Hebestreit, Alexandra
    Schindler, Christian
    Stuessi, Christoph
    Hebestreit, Helge
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 714 - 720
  • [24] Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher
    Szczesniak, Rhonda
    Heltshe, Sonya L.
    Stanojevic, Sanja
    Mayer-Hamblett, Nicole
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 318 - 326
  • [25] Factors associated with acid-fast bacillus isolation in patients with noncystic fibrosis bronchiectasis: A cross-sectional study
    Takeno, Yukiko
    Komiya, Kosaku
    Mizukami, Eri
    Hiramatsu, Kazufumi
    Kadota, Jun-ichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (07) : 688 - 692
  • [26] Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis
    Sanders, Don B.
    Emerson, Julia
    Ren, Clement L.
    Schechter, Michael S.
    Gibson, Ronald L.
    Morgan, Wayne
    Rosenfeld, Margaret
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (08) : 1170 - 1176
  • [27] Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany
    Dittrich, A. Susanne
    Dumke, Markus
    Kapl, Ferdinand
    Schneider, Philipp
    Wege, Sabine
    Graeber, Simon
    Stahl, Mirjam
    Herth, Felix J.
    Naehrlich, Lutz
    Mall, Marcus A.
    Sommburg, Olaf
    RESPIRATION, 2023, 102 (05) : 351 - 360
  • [28] Total oxidant and antioxidant status and paraoxonase 1 levels of children with noncystic fibrosis bronchiectasis
    Gedik, Ahmet Hakan
    Cakir, Erkan
    Vehapoglu Turkmen, Aysel
    Ozer, Omer Faruk
    Kaygusuz, Sare Betul
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (01) : 1 - 7
  • [29] The importance of data issues when comparing cystic fibrosis registry outcomes between countries: Are annual review FEV1 in the UK only collected when subjects are well?
    Hoo, Zhe Hui
    Curley, Rachael
    Campbell, Michael J.
    Walters, Stephen J.
    Wildman, Martin J.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2018, 24 (04) : 745 - 751
  • [30] Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis
    Kaditis, Athanasios G.
    Miligkos, Michael
    Bossi, Anna
    Colombo, Carla
    Hatziagorou, Elpis
    Kashirskaya, Nataliya
    de Monestrol, Isabelle
    Thomas, Muriel
    Mei-Zahav, Meir
    Chrousos, George
    Zolin, Anna
    ARCHIVES OF DISEASE IN CHILDHOOD, 2017, 102 (08) : 742 - 747